Ticker Symbol: VRDN

Viridian Therapeutics Inc

$18.78 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001590750

Company Profile

Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.

Sector: Health Care and Social Assistance

Industry: Medical Laboratories

Standard Industrial Classification Code (SIC code): 8071

Address: 6200 Lookout Rd

Website: www.viridiantherapeutics.com

CEO: William Marshall

Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $14.09

Change: -$0.51 ( -3.49%)

Days Range: $13.75 - $14.53

Beta: 0.78

52wk. High: $39.00

52wk. Low: $11.44

Ytd. Change -53.51%

50 Day Moving Average: $15.23

200 Day Moving Average: $21.29

Shares Outstanding: 43670157

Valuation

Market Cap: 61.5B

PE Ratio: -

EPS (TTM): -4.95

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A